| ||||||||||||||
|
|
|||||||||||||


*Department of Anesthesiology, University of Washington, Seattle, Washington;
Department of Pharmacology, Rush Medical College, Chicago; and
Pharmaconsultant, Inc., Palatine, Illinois
Address correspondence and reprint requests to Michael J. Bishop, MD, Anesthesiology and Medicine (Adjunct), University of Washington School of Medicine, VA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108. Address e-mail to bish{at}u.washington.edu
IMPLICATIONS: Because of case reports of severe bronchospasm after the use of mivacurium, we used the Food and Drug Administration MedWatch database to determine the frequency of bronchospasm as an adverse event after the use of nondepolarizing muscle relaxants.
This article has been cited by other articles:
![]() |
S. M. Katz and M. J. Bishop Mivacurium and Bronchospasm * Response Anesth. Analg., January 1, 2004; 98(1): 272 - 272. [Full Text] [PDF] |
||||
|